[HTML][HTML] Nanomedicine for acute respiratory distress syndrome: the latest application, targeting strategy, and rational design

Q Qiao, X Liu, T Yang, K Cui, L Kong, C Yang… - … Pharmaceutica Sinica B, 2021 - Elsevier
Acute respiratory distress syndrome (ARDS) is characterized by the severe inflammation
and destruction of the lung air–blood barrier, leading to irreversible and substantial …

Comparison of COVID-19 induced respiratory failure and typical ARDS: similarities and differences

S Lu, X Huang, R Liu, Y Lan, Y Lei, F Zeng… - Frontiers in …, 2022 - frontiersin.org
Coronavirus disease 2019 (COVID-19) is a predominantly respiratory infectious disease
caused by novel coronavirus infection (SARS-CoV-2), respiratory failure is the main clinical …

The role of lung macrophages in acute respiratory distress syndrome

W Dang, Y Tao, X Xu, H Zhao, L Zou, Y Li - Inflammation Research, 2022 - Springer
Acute respiratory distress syndrome (ARDS) is an acute and diffuse inflammatory lung injury
in a short time, one of the common severe manifestations of the respiratory system that …

Novel insights into the treatment of SARS-CoV-2 infection: An overview of current clinical trials

F Oroojalian, A Haghbin, B Baradaran… - International Journal of …, 2020 - Elsevier
The emergence of the global pandemic caused by the novel SARS-CoV-2 virus has
motivated scientists to find a definitive treatment or a vaccine against it in the shortest …

Therapeutic applications of stem cells and extracellular vesicles in emergency care: futuristic perspectives

S Öztürk, AE Elçin, A Koca, YM Elçin - Stem Cell Reviews and Reports, 2021 - Springer
Regenerative medicine (RM) is an interdisciplinary field that aims to repair, replace or
regenerate damaged or missing tissue or organs to function as close as possible to its …

Dehydrozingerone ameliorates Lipopolysaccharide induced acute respiratory distress syndrome by inhibiting cytokine storm, oxidative stress via modulating the …

SK Tirunavalli, K Gourishetti, RSS Kotipalli, M Kuncha… - Phytomedicine, 2021 - Elsevier
Background Inflammation-mediated lung injury is a major cause of health problems in many
countries and has been the leading cause of morbidity/mortality in intensive care units. In the …

Pulmonary drug delivery for acute respiratory distress syndrome

Q Fei, I Bentley, SN Ghadiali, JA Englert - Pulmonary Pharmacology & …, 2023 - Elsevier
The acute respiratory distress syndrome (ARDS) is a life-threatening condition that causes
respiratory failure. Despite numerous clinical trials, there are no molecularly targeted …

Luteolin regulates the differentiation of regulatory T cells and activates IL‐10‐dependent macrophage polarization against acute lung injury

K Xie, Y Chai, S Lin, F Xu… - Journal of immunology …, 2021 - Wiley Online Library
Objectives. Inflammatory disease characterized by clinical destructive respiratory disorder is
called acute lung injury/acute respiratory distress syndrome (ALI/ARDS). Studies have …

Translational medicine for acute lung injury

J Zhang, Y Guo, M Mak, Z Tao - Journal of Translational Medicine, 2024 - Springer
Acute lung injury (ALI) is a complex disease with numerous causes. This review begins with
a discussion of disease development from direct or indirect pulmonary insults, as well as …

Nanomedicine-based therapeutics to combat acute lung injury

S Bian, H Cai, Y Cui, W Liu, C Xiao - International Journal of …, 2021 - Taylor & Francis
Acute lung injury (ALI) or its aggravated stage acute respiratory distress syndrome (ARDS)
may lead to a life-threatening form of respiratory failure, resulting in high mortality of up to 30 …